GlassScriptPhysician profile
Derrick J Sanderson
NPI 1043577448
$2,339.20
in general payments reported to CMS, 2019-2025
23 companies · $50.02 in 2025
The $50.02 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $338 · 2021: $438 · 2022: $892 · 2023: $384 · 2025: $50.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $599.37 | 2020-2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $424.10 | 2019-2020 | |
| Medtronic, INC. | $302.99 | 2021-2023 | Interstim |
| Astellas Pharma US INC | $192.69 | 2020-2021 | |
| Aspira Women'S Health INC | $187.86 | 2022-2023 | Ova1 |
| Caldera Medical, INC | $144.60 | 2021-2022 | |
| Boston Scientific Corporation | $103.96 | 2022 | |
| Exeltis, USA INC. | $51.72 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $50.02 | 2025 | Novasure, Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $40.13 | 2021-2022 | |
| Therapeuticsmd, INC. | $39.77 | 2020-2022 | |
| Pfizer INC. | $31.07 | 2022 | |
| Ambu INC. | $25.25 | 2021 | |
| Pharmacosmos Therapeutics INC. | $20.20 | 2023 | Monoferric |
| Channel Medsystems, INC. | $16.96 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $15.52 | 2022 | |
| Myovant Sciences INC. | $14.58 | 2022 | |
| Mayne Pharma Commercial LLC | $14.09 | 2022 | |
| Coopersurgical, INC. | $14.00 | 2023 | Paragard T 380a |
| Meditrina | $13.75 | 2023 | |
| Allergan, INC. | $13.58 | 2020 | |
| Urocure LLC | $12.42 | 2019 | |
| Organon LLC | $10.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Sanderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.